ESC MEDICAL SYSTEMS LTD
SC 13D/A, 1999-06-18
MEDICAL, DENTAL & HOSPITAL EQUIPMENT & SUPPLIES
Previous: SPINTEK GAMING TECHNOLOGIES INC \CA\, S-8, 1999-06-18
Next: ESC MEDICAL SYSTEMS LTD, SC 13D/A, 1999-06-18





                     SECURITIES AND EXCHANGE COMMISSION
                          WASHINGTON, D.C.  20549

                                SCHEDULE 13D
                               (Rule 13d-101)


           INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
          TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO
                                RULE 13d-2(a)

                             (Amendment No. 14)


                          ESC Medical Systems Ltd.
               ---------------------------------------------
                             (Name of Issuer)

               Ordinary Shares, NIS 0.10 par value per share
               ---------------------------------------------
                     (Title of Class of Securities)

                                 M40868107
               ---------------------------------------------
                              (CUSIP Number)


                            Barnard J. Gottstein
                          Carr-Gottstein Properties
                      550 West 77th Avenue, Suite 1540
                          Anchorage, Alaska 99501
                              (907) 278-2277
             -------------------------------------------------
               (Name, Address and Telephone Number of Person
              Authorized to Receive Notices and Communications)


                              with a copy to:

                           Joseph J. Giunta, Esq.
                  Skadden, Arps, Slate, Meagher & Flom LLP
                     300 South Grand Avenue, Suite 3400
                    Los Angeles, California  90071-3144
                               (213) 687-5000


                                 June 17, 1999
          -------------------------------------------------------
          (Date of Event which Requires Filing of This Statement)


 If the filing person has previously filed a statement on Schedule 13G to
 report the acquisition that is the subject of this Schedule 13D, and is
 filing this schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check
 the following box:
                                                 [  ]



      This Amendment No. 14 (the "Amendment") amends and supplements the
 Statement on Schedule 13D, dated September 29, 1998, as amended by
 Amendment No. 1, dated January 15, 1999, Amendment No. 2, dated March 9,
 1999, Amendment No. 3, dated March 22, 1999, Amendment No. 4, dated March
 24, 1999, Amendment No. 5, dated April 14, 1999, Amendment No. 6, dated
 April 19, 1999, Amendment No. 7, dated May 10, 1999, Amendment No. 8, dated
 May 11, 1999, Amendment No. 9, dated May 20, 1999, Amendment No. 10, dated
 May 27, 1999, Amendment No. 11, dated May 29, 1999, Amendment No. 12, dated
 June 15, 1999, and Amendment No. 13, dated June 16, 1999 (the "Original
 Schedule 13D"), relating to the Ordinary Shares, par value NIS 0.10 per
 share (the "Shares"), of ESC Medical Systems Ltd., an Israeli corporation
 (the "Company").  Each of the Barnard J. Gottstein Revocable Trust, Barnard
 J. Gottstein, as trustee of the Barnard J. Gottstein Revocable Trust, and
 Barnard J. Gottstein, as an individual (collectively, the "Reporting
 Persons"), are filing this Amendment to update the information with respect
 to the Reporting Persons' purposes and intentions with respect to the
 Shares.

 ITEM 4.   PURPOSE OF TRANSACTION.

       Item 4 of the Original Schedule 13D is hereby amended and
 supplemented as follows:

           On June 17, 1999, the legal representatives of Messrs. Genger
 and Gottstein filed three motions in an Israeli court, seeking declaratory
 relief on the validity of their proxies, for an injunction against the
 trustee of the Company's stock option plans from voting the shares
 purportedly held by the trustee, and for an order of contempt of court for
 the Company's failure to deliver in a timely manner to Messrs. Genger and
 Gottstein a complete list of all shareholders of the Company. The hearing
 on at least one of the motions is scheduled to occur on June 22, 1999. In
 addition to filing a motion, Messrs. Genger and Gottstein have questioned
 the legal representative of the Company as to why, if the Company seeks to
 have the trustee vote such shares at the June 23 meeting of shareholders,
 the Company has failed to file any Schedule 13D or 13G with the Securities
 and Exchange Commission disclosing the Company's ownership and intention
 with respect to such shares.

       Other than as described above and as previously described in the
 Original Schedule 13D, the Reporting Persons do not have any present plans
 or proposals which relate to or would result in (although they reserve the
 right to develop such plans or proposals) any transaction, change or event
 specified in clauses (a) through (j) of Item 4 of the form of Schedule 13D.


                                 SIGNATURE

           After reasonable inquiry and to the best of my knowledge and
 belief, I certify that the information set forth in this statement is true,
 complete and correct.

 Dated: June 17, 1999


                                /s/ Barnard J. Gottstein
                                -------------------------------------
                                Barnard J. Gottstein
                                Individually and as Trustee of the
                                Barnard J. Gottstein Revocable Trust


                                BARNARD J. GOTTSTEIN REVOCABLE TRUST


                                /s/ Barnard J. Gottstein
                                ------------------------------------
                                Barnard J. Gottstein
                                Trustee






© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission